Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Adaptin Bio, Inc.

OTC: APTN · Life Sciences · 1 alert · CIK 1938571

Shares outstanding
9.26MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Adaptin Bio, Inc. filings on SEC EDGAR ↗

4:08 PM ET 10-Q
Financial Results

Adaptin Bio Q3 2026 Results: Net Loss of $957K, Loss Narrows

Adaptin Bio, Inc. reported a net loss of $3.31 million for the nine months ended September 30, 2026, compared to a $3.80 million loss in the prior year period. The company remains in the development stage with no revenue, maintaining a stockholders' deficit of $1.67 million and a cash balance of $430,333 as of the reporting date.

Key figure
Net loss $957K

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.